EUVIMEDEUVIMED entdecken
Crossref

Trifluoro-Icaritin Ameliorates Neuroinflammation Against Complete Freund’s Adjuvant-Induced Microglial Activation by Improving CB2 Receptor-Mediated IL-10/β-endorphin Signaling in the Spinal Cord of Rats

Guangsen Liu, Dandan Jia, Weiwei Li, Zhihua Huang, Reai Shan, Cheng Huang

Journal of Neuroimmune Pharmacology · 2024

DOI: 10.1007/s11481-024-10152-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroimmune Pharmacology, 2024. Verfasst von Guangsen Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Gannan Medical University, Ganzhou, 341000, P. R. China. Hauptthemen laut MEDLINE: beta-Endorphin, Freund's Adjuvant, Interleukin-10, Microglia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Science and Technology Project of Administration of Chinese Medicine, Jiangxi Province, China, Horizontal Project of Gannan Medical University, Jiangxi Province, China, University-level Key Project of Gannan Medical University, Jiangxi Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The underlying pathogenesis of chronic inflammatory pain is greatly complex, but the relevant therapies are still unavailable. Development of effective candidates for chronic inflammatory pain is highly urgent. We previously identified that trifluoro-icaritin (ICTF) exhibited a significant therapeutic activity against complete Freund's adjuvant (CFA)-induced chronic inflammatory pain, however, the precise mechanisms remain elusive. Here, the paw withdrawal threshold (PWT), paw withdrawal latency (PWL), and CatWalk gait analysis were used to determine the pain-related behaviors. The expression and co-localization of pain-related signaling molecules were detected by Western blot and immunofluorescence staining. Our results demonstrated that ICTF (3.0 mg/kg, i.p.) effectively attenuated mechanical allodynia, thermal hyperalgesia and improved motor dysfunction induced by CFA, and the molecular docking displayed that CB2 receptor may be the therapeutic target of ICTF. Furthermore, ICTF not only up-regulated the levels of CB2 receptor, IL-10, β-endorphin and CD206, but also reduced the expression of P2Y12 receptor, NLRP3, ASC, Caspase-1, IL-1β, CD11b, and iNOS in the spinal cord of CFA rats. Additionally, the immunofluorescence staining from the spinal cord showed that ICTF significantly increased the co-expression between the microglial marker Iba-1 and CB2 receptor, IL-10, β-endorphin, respectively, but markedly decreased the co-localization between Iba-1 and P2Y12 receptor. Conversely, intrathecal administration of CB2 receptor antagonist AM630 dramatically reversed the inhibitory effects of ICTF on CFA-induced chronic inflammatory pain, leading to a promotion of pain hypersensitivity, abnormal gait parameters, microglial activation, and up-regulation of P2Y12 receptor and NLRP3 inflammasome, as well as the inhibition of CB2 receptor and IL-10/β-endorphin cascade. Taken together, these findings highlighted that ICTF alleviated CFA-induced neuroinflammation by enhancing CB2 receptor-mediated IL-10/β-endorphin signaling and suppressing microglial activation in the spinal cord, and uncovered that CB2 receptor may be exploited as a novel and promising target for ICTF treatment of chronic inflammatory pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-EndorphinFreund's AdjuvantInterleukin-10MicrogliaNeuroinflammatory DiseasesReceptor, Cannabinoid, CB2Signal TransductionSpinal CordAnimalsMaleRatsFlavonoidsHyperalgesiaRats, Sprague-Dawley

Stichwörter der Autor:innen

CB2 receptorChronic inflammatory painIL-10/β-endorphin signalingNeuroinflammationTrifluoro-icaritin

Substanzen

beta-EndorphinCnr2 protein, ratFlavonoidsFreund's AdjuvantInterleukin-10Receptor, Cannabinoid, CB2

Autor:innen und Institutionen

  • First Clinical Medical College, Gannan Medical University, Ganzhou, 341000, P. R. China.
  • Department of Physiology, School of Basic Medicine Sciences, Gannan Medical University, Ganzhou, 341000, P. R. China.
  • School of Public Health and Health management, Gannan Medical University, Ganzhou, 341000, P. R. China.
  • First Clinical Medical College, Gannan Medical University, Ganzhou, 341000, P. R. China. shanreai@163.com.
  • Department of Anesthesiology, First Affiliated Hospital of Gannan Medical University, Jiangxi, 341000, P. R. China. shanreai@163.com.
  • Ganzhou Key Laboratory of Anesthesiology, Ganzhou, 341000, P. R. China. shanreai@163.com.

Förderung

  • Science and Technology Project of Administration of Chinese Medicine, Jiangxi Province, China
  • Horizontal Project of Gannan Medical University, Jiangxi Province, China
  • University-level Key Project of Gannan Medical University, Jiangxi Province, China
  • Health Commission General Science and Technology Program, Jiangxi Province, China
  • National Natural Science Foundation of China
  • Talent Project of Department of Scientific and Technology, Jiangxi Province, China

Zitieren

APA

Liu, G., Jia, D., Li, W., Huang, Z., Shan, R., & Huang, C. (2024). Trifluoro-Icaritin Ameliorates Neuroinflammation Against Complete Freund’s Adjuvant-Induced Microglial Activation by Improving CB2 Receptor-Mediated IL-10/β-endorphin Signaling in the Spinal Cord of Rats. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-024-10152-8

Vancouver

Liu G, Jia D, Li W, Huang Z, Shan R, Huang C. Trifluoro-Icaritin Ameliorates Neuroinflammation Against Complete Freund’s Adjuvant-Induced Microglial Activation by Improving CB2 Receptor-Mediated IL-10/β-endorphin Signaling in the Spinal Cord of Rats. Journal of Neuroimmune Pharmacology. 2024. doi:10.1007/s11481-024-10152-8

BibTeX
@article{Liu2024,
  author = {Liu, Guangsen and Jia, Dandan and Li, Weiwei and Huang, Zhihua and Shan, Reai and Huang, Cheng},
  title = {Trifluoro-Icaritin Ameliorates Neuroinflammation Against Complete Freund’s Adjuvant-Induced Microglial Activation by Improving CB2 Receptor-Mediated IL-10/β-endorphin Signaling in the Spinal Cord of Rats},
  journal = {Journal of Neuroimmune Pharmacology},
  year = {2024},
  doi = {10.1007/s11481-024-10152-8}
}
Kostenlos starten →